Livermore

JOHNSON & JOHNSON

SEC CIK
0000200406

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 6, 2026.SEC

Positions
15
−1 vs. Q1 2026
Total value
$798.65M
+$146.29M (+22.4%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

JOHNSON & JOHNSON holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
PTGXPROTAGONIST THERAPEUTICS INCCOM2,449,183$300.22M37.59%00.0%UnchangedView
NBTXNANOBIOTIX SASPONSORED ADS5,623,816$212.02M26.55%00.0%UnchangedView
MGTXMEIRAGTX HLDGS PLCCOM6,641,064$89.72M11.23%00.0%UnchangedView
RAPPRAPPORT THERAPEUTICS INCCOM1,784,517$74.36M9.31%00.0%UnchangedView
CTNMCONTINEUM THERAPEUTICS INCCL A1,979,173$32.44M4.06%00.0%UnchangedView
LEGNLEGEND BIOTECH CORPSPONSORED ADS814,586$23.53M2.95%00.0%UnchangedView
CVRXCVRX INCCOM4,024,861$20.69M2.59%00.0%UnchangedView
XNCRXENCOR INCCOM748,062$12.04M1.51%00.0%UnchangedView
CBRSCEREBRAS SYSTEMS INCCOM CL A53,586$11.84M1.48%+53,586NewView
FATEFATE THERAPEUTICS INCCOM3,379,064$9.12M1.14%00.0%UnchangedView
PRCTPROCEPT BIOROBOTICS CORPCOM357,939$8.08M1.01%00.0%UnchangedView
NMRANEUMORA THERAPEUTICS INC.COM1,849,445$3.14M0.39%00.0%UnchangedView
VORVOR BIOPHARMA INCCOM NEW53,732$989.21K0.12%00.0%UnchangedView
LABSTANDARD BIOTOOLS INCCOM311,967$256.66K0.03%00.0%UnchangedView
ACETADICET BIO INCCOM NEW22,779$196.81K0.02%00.0%UnchangedView

Sold out since Q1 2026 (2)

Positions held at the end of Q1 2026 that are no longer in this filing.

JOHNSON & JOHNSON positions sold out since Q1 2026
SecurityClassShares, Q1 2026Value, Q1 2026% of portfolio, Q1 2026
RLYBRALLYBIO CORPCOM152,901$1.37M0.21%
NNOXNANO X IMAGING LTDORD SHS83,554$189.67K0.03%

13F filings by quarter

JOHNSON & JOHNSON 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 6, 202615$798.65Mvs. Q1 2026SEC
Q1 2026May 13, 202616$652.36Mvs. Q4 2025SEC
Q4 2025Mar 18, 2026Amended17$555.05Mvs. Q3 2025SEC
Q3 2025Mar 18, 2026Amended20$503.92Mvs. Q2 2025SEC
Q2 2025Jul 22, 202520$334.1Mvs. Q1 2025SEC
Q1 2025May 7, 202520$341.87Mvs. Q4 2024SEC
Q4 2024Feb 13, 202520$386.13Mvs. Q3 2024SEC
Q3 2024Nov 13, 202420$427.33Mvs. Q2 2024SEC
Q2 2024Aug 9, 202420$400.67Mvs. Q1 2024SEC
Q1 2024May 10, 202422$4.41Bvs. Q4 2023SEC
Q4 2023Feb 14, 202423$4.39Bvs. Q3 2023SEC
Q3 2023Nov 9, 202324$271.47Mvs. Q2 2023SEC
Q2 2023Aug 2, 202322$322.07Mvs. Q1 2023SEC
Q1 2023May 11, 202323$307.42Mvs. Q4 2022SEC
Q4 2022Feb 9, 202322$343.71Mvs. Q3 2022SEC
Q3 2022Nov 10, 202222$339.82Mvs. Q2 2022SEC
Q2 2022Aug 10, 202222$391.45Mvs. Q1 2022SEC
Q1 2022May 9, 202222$528.97Mvs. Q4 2021SEC
Q4 2021Feb 14, 202224$878.42Mvs. Q3 2021SEC
Q3 2021Nov 16, 2021Amended25$1.14B–SEC